Broadcast Date: July 8, 2021
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Discovery of RNA therapies, such as antisense oligonucleotides, small interfering RNA, and, somewhat topically, mRNA vaccines, is becoming an increasingly important component of drug discovery research. This applies to both smaller companies focused on specific therapeutic types and to large biopharma, who often apply a multi-modal (i.e., “whatever works”) approach to solving disease problems. A feature of this research is that it typically involves cross-functional teams of chemists and biologists, working together to drive innovations for the types of chemical modifications of RNAs that are required to optimize efficacy and drug metabolism and pharmacokinetic property profiles. In order for these teams to work effectively and productively, it is critical that data capture, management, and analysis systems are able to handle these novel entity types and present data in ways that suit the respective needs of the team. This means that informatics systems must be equally adept at storing and representing the same entity as both a chemical structure and biological sequence.
In this GEN webinar, we will highlight the key features of an informatics solution that supports research of RNA therapeutic candidates, supporting the respective needs of chemists and biologists. Our panelists will describe how to find all the data you need for informed decision-making in RNA therapies research, as well as how cross-functional teams of chemists, biologists, and screening scientists are supported during the process. The presenters will show examples of how your valuable intellectual property is defined, stored, and protected. They will conclude the webinar by providing solutions for how to integrate the informatics platform with best-in-class desktop applications such as SnapGene and GraphPad Prism.
A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.
Produced with support from: